ロード中...
Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
Ductal carcinoma in situ of the breast is a non-obligate precursor of invasive breast cancer, and at its lower risk end might not need treatment, a hypothesis tested in several currently running randomized clinical trials. This review describes the heterogeneity of grading ductal carcinoma in situ (...
保存先:
| 出版年: | Pathol Oncol Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Netherlands
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7242244/ https://ncbi.nlm.nih.gov/pubmed/31776839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12253-019-00760-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|